November 8, 2021 William P. Burke Address on file with the Company RE: CFO Retention and Transition Agreement Dear Bill:Retention and Transition Agreement • February 8th, 2022 • Haemonetics Corp • Surgical & medical instruments & apparatus
Contract Type FiledFebruary 8th, 2022 Company IndustryThis Retention and Transition Agreement (this “Agreement”) sets forth the understanding between you and Haemonetics Corporation (the “Company”) regarding your continued employment as Chief Financial Officer of the Company and your planned retirement from the Company and transition. On behalf of the Board of Directors of the Company, I want to thank you for your willingness to provide continued service as Chief Financial Officer and then in the role of Special Advisor as provided in this Agreement in order to ensure a seamless and successful transition to the next Chief Financial Officer of the Company.
FOURTEENTH AMENDMENT TO AGREEMENT OF LEASE DATED THIS 11th DAY OF NOVEMBER, 2021 BY AND BETWEENHaemonetics Corp • February 8th, 2022 • Surgical & medical instruments & apparatus
Company FiledFebruary 8th, 2022 IndustryTHE BUNCHER COMPANY, as Landlord, a Pennsylvania corporation having its principal office in the City of Pittsburgh, Allegheny County, Pennsylvania,